Literature DB >> 11601802

Interstitial cystitis: urgency and frequency syndrome.

J F Metts1.   

Abstract

Interstitial cystitis is a chronic, severely debilitating disease of the urinary bladder. Excessive urgency and frequency of urination, suprapubic pain, dyspareunia, chronic pelvic pain and negative urine cultures are characteristic of interstitial cystitis. The course of the disease is usually marked by flare-ups and remissions. Other conditions that should be ruled out include bacterial cystitis, urethritis, neoplasia, vaginitis and vulvar vestibulitis. Interstitial cystitis is diagnosed by cystoscopy and hydrodistention of the bladder. Glomerulations or Hunner's ulcers found at cystoscopy are diagnostic. Oral treatments of interstitial cystitis include pentosan polysulfate, tricyclic antidepressants and antihistamines. Intravesicular therapies include hydrodistention, dimethyl sulfoxide and heparin, or a combination of agents. Referral to a support group should be offered to all patients with interstitial cystitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11601802

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  17 in total

Review 1.  Minimally invasive therapies for chronic pelvic pain syndrome.

Authors:  Salim A Wehbe; Jennifer Y Fariello; Kristene Whitmore
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

2.  Mesenchymal Stem Cell Therapy Alleviates Interstitial Cystitis by Activating Wnt Signaling Pathway.

Authors:  Miho Song; Jisun Lim; Hwan Yeul Yu; Junsoo Park; Ji-Youn Chun; Jaeho Jeong; Jinbeom Heo; Hyunsook Kang; YongHwan Kim; Yong Mee Cho; Seong Who Kim; Wonil Oh; Soo Jin Choi; Sung-Wuk Jang; Sanghyeok Park; Dong-Myung Shin; Myung-Soo Choo
Journal:  Stem Cells Dev       Date:  2015-04-09       Impact factor: 3.272

3.  Association of bladder pain syndrome/interstitial cystitis with urinary calculus: a nationwide population-based study.

Authors:  Joseph Keller; Yi-Kuang Chen; Herng-Ching Lin
Journal:  Int Urogynecol J       Date:  2012-08-16       Impact factor: 2.894

4.  Dissimilar effects of tolterodine on detrusor overactivity in awake rats with chemical cystitis and partial bladder outlet obstruction.

Authors:  Long-Hu Jin; Chang-Shin Park; Hwa-Yeon Shin; Sang-Min Yoon; Tack Lee
Journal:  Int Neurourol J       Date:  2011-09-30       Impact factor: 2.835

5.  A survey of primary care physician practices in the diagnosis and management of women with interstitial cystitis/painful bladder syndrome.

Authors:  J Quentin Clemens; Elizabeth A Calhoun; Mark S Litwin; Elizabeth Walker-Corkery; Talar Markossian; John W Kusek; Mary McNaughton-Collins
Journal:  Urology       Date:  2010-03-19       Impact factor: 2.649

6.  Interstitial Cystitis: Cost, treatment and co-morbidities in an employed population.

Authors:  Eric Q Wu; Howard Birnbaum; Milena Mareva; Andrew Parece; Zihong Huang; David Mallett; Haya Taitel
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

7.  Role of inflammation in bladder function and interstitial cystitis.

Authors:  Sonal Grover; Abhishek Srivastava; Richard Lee; Ashutosh K Tewari; Alexis E Te
Journal:  Ther Adv Urol       Date:  2011-02

8.  Diagnosis of interstitial cystitis/ painful bladder syndrome in patients with overactive bladder symptoms.

Authors:  Scott A Macdiarmid; Peter K Sand
Journal:  Rev Urol       Date:  2007

9.  Treatment of interstitial cystitis with hydrodistention and bladder training.

Authors:  Ching-Hung Hsieh; Shao-Tung Chang; Chia-Jung Hsieh; Chun-Sen Hsu; Tsung-Cheng Kuo; Hui-Chin Chang; Yi-Hui Lin
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-05-22

10.  Urological chronic pelvic pain syndrome symptom flares: characterisation of the full range of flares at two sites in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.

Authors:  Siobhan Sutcliffe; Graham A Colditz; Melody S Goodman; Ratna Pakpahan; Joel Vetter; Timothy J Ness; Gerald L Andriole; H Henry Lai
Journal:  BJU Int       Date:  2014-08-11       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.